Label: BENZTROPINE MESYLATE tablet
- NDC Code(s): 70518-0132-0, 70518-0132-1
- Packager: REMEDYREPACK INC.
- This is a repackaged label.
- Source NDC Code(s): 0603-2434
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated April 22, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
SPL UNCLASSIFIED SECTIONRx only
-
DESCRIPTIONBenztropine mesylate is a synthetic compound containing structural features found in atropine and diphenhydramine. It is a crystalline white powder, very soluble in water, designated as ...
-
CLINICAL PHARMACOLOGYBenztropine mesylate possesses both anticholinergic and antihistaminic effects, although only the former have been established as therapeutically significant in the management of parkinsonism. In ...
-
INDICATIONS AND USAGEFor use as an adjunct in the therapy of all forms of parkinsonism. Useful also in the control of extrapyramidal disorders (except tardive dyskinesia – see - PRECAUTIONS) due to ...
-
CONTRAINDICATIONSHypersensitivity to benztropine mesylate tablets. Because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with ...
-
WARNINGSSafe use in pregnancy has not been established. Benztropine mesylate may impair mental and/or physical abilities required for performance of hazardous tasks, such as operating machinery or driving ...
-
PRECAUTIONSGeneral - Since benztropine mesylate has cumulative action, continued supervision is advisable. Patients with a tendency to tachycardia and patients with prostatic hypertrophy should be observed ...
-
ADVERSE REACTIONSThe adverse reactions below, most of which are anticholinergic in nature, have been reported and within each category are listed in order of decreasing severity. Cardiovascular Tachycardia ...
-
OVERDOSAGEManifestations - May be any of those seen in atropine poisoning or antihistamine overdosage; CNS depression, preceded or followed by stimulation; confusion; nervousness; listlessness ...
-
DOSAGE AND ADMINISTRATIONBenztropine mesylate tablets should be used when patients are able to take oral medication. Because of cumulative action, therapy should be initiated with a low dose which is increased gradually ...
-
HOW SUPPLIEDBenztropine Mesylate Tablets, USP are available as follows: 1 mg: white, oval, scored tablets, debossed "2326" on one side and debossed "V" on the reverse side, supplied in - NDC: 70518-0132-00 - NDC ...
-
SPL UNCLASSIFIED SECTIONRepackaged and Distributed By: Remedy Repack, Inc. 625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762
-
PRINCIPAL DISPLAY PANELDRUG: Benztropine Mesylate - GENERIC: benztropine mesylate - DOSAGE: TABLET - ADMINSTRATION: ORAL - NDC: 70518-0132-0 - NDC: 70518-0132-1 - COLOR: white - SHAPE: OVAL - SCORE: Two even pieces - SIZE: 10 mm - IMPRINT ...
-
INGREDIENTS AND APPEARANCEProduct Information